Recombinant Listeria monocytogenes as a live vaccine vehicle and a probe for studying cell-mediated immunity

E R Jensen1, H Shen, F O Wettstein

  • 1Department of Microbiology and Immunology, University of California at Los Angeles School of Medicine, USA.

Immunological Reviews
|August 1, 1997
PubMed

Insights

Listeria monocytogenes can be engineered as a vaccine vehicle to induce long-term immunity. Recombinant Listeria strains expressing foreign antigens successfully generated protective CD8+ T-cell responses in animal models.

Area of Science:

  • Immunology
  • Microbiology
  • Vaccinology

Background:

  • Listeria monocytogenes' cytosolic entry facilitates antigen presentation via MHC class I.
  • L. monocytogenes is a promising live vaccine vehicle for heterologous antigens.
  • Induction of immunological memory and CD8+ T-cell responses are key vaccine goals.

Purpose of the Study:

  • To establish a genetic system for regulated antigen expression and secretion by recombinant Listeria.
  • To evaluate the capacity of these recombinant strains to induce long-term immunological memory and protective immunity.
  • To assess the efficacy of L. monocytogenes-based vaccines in viral and tumor models.

Main Methods:

  • Developed a site-specific genetic integration system for antigen expression cassettes in Listeria.
  • Utilized lymphocytic choriomeningitis virus (LCMV) model in mice to assess CD8+ T-cell induction and protection.
  • Employed a cottontail rabbit papillomavirus model in rabbits to evaluate antitumor immunity.

Main Results:

  • Recombinant Listeria strains expressing LCMV antigens successfully induced LCMV-specific CD8+ T cells in mice.
  • Vaccinated mice demonstrated protection against LCMV challenge.
  • Recombinant Listeria stimulated protective antitumor immunity in a rabbit papillomavirus model.

Conclusions:

  • Recombinant L. monocytogenes vaccines demonstrate protective efficacy against viral challenge and tumors.
  • The established experimental system enables systematic analysis of cytotoxic T-cell induction by intracellular bacteria.
  • L. monocytogenes serves as an effective platform for developing vaccines against various pathogens and cancers.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...